In RA, available data suggest that the complement system, mainly the classical pathway, contributes to tissue damage especially in ACPA positive subjects, and that complement activation mostly occurs locally in the joint microenvironment. This evidence concerns the gene PRTN3 and rheumatoid arthritis.